Ha; Nina

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ha; Nina.The latest application filed is for "pharmaceutical composition comprising histone deacetylase inhibitor and methotrexate".

Company Profile

3.7.17

Ha; Nina - Gyeonggi-do KR
Ha; Nina - Yongin-si KR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pharmaceutical composition comprising histone deacetylase inhibitor and methotrexate App 20220296599 - Choi; Young II ; et al.	2022-09-22
Heterocyclicalkyl derivative compounds as selective histone deacetylase inhibitors and pharmaceutical compositions comprising the same Grant 11,420,950 - Lee , et al. August 23, 2	2022-08-23
Pharmaceutical Composition Comprising Histone Deacetylase 6 Inhibitors App 20220008414 - Choi; Young II ; et al.	2022-01-13
Compositions for Preventing or Treating Dry Eye App 20210161905 - Choi; Young II ; et al.	2021-06-03
Compositions For Preventing Or Treating Uveitis App 20210077501 - Choi; Young II ; et al.	2021-03-18
Compositions For Preventing Or Treating Lupus App 20200368245 - Choi; Young Il ; et al.	2020-11-26
Compounds as histone deacetylase 6 inhibitors and pharmaceutical compositions comprising the same Grant 10,287,255 - Song , et al.	2019-05-14
Heterocyclicalkyl Derivative Compounds As Selective Histone Deacetylase Inhibitors And Pharmaceutical Compositions Comprising The Same App 20180312482 - LEE; Changsik ; et al.	2018-11-01
Compounds for selective histone deacetylase inhibitors, and pharmaceutical composition comprising the same Grant 9,878,986 - Lee , et al. January 30, 2	2018-01-30
Novel Compounds For Selective Histone Deacetylase Inhibitors, And Pharmaceutical Composition Comprising The Same App 20170152230 - LEE; Changsik ; et al.	2017-06-01
Azaindole derivatives as selective histone deacetylase (HDAC) inhibitors and pharmaceutical compositions comprising the same Grant 9,650,379 - Lee , et al. May 16, 2	2017-05-16
Novel Compounds As Histone Deacetylase 6 Inhibitors And Pharmaceutical Compositions Comprising The Same App 20170096405 - SONG; Hyeseung ; et al.	2017-04-06
Novel Indole Derivative Compound And Pharmaceutical Composition Comprising The Same App 20160355475 - LEE; Changsik ; et al.	2016-12-08
Novel Azaindole Derivatives As Selective Histone Deacetylase (hdac) Inhibitors And Pharmaceutical Compositions Comprising The Same App 20160289230 - LEE; Changsik ; et al.	2016-10-06
N-acylhydrazone derivatives for selective T cell inhibitor and anti-lymphoid malignancy drug Grant 9,447,083 - Choi , et al. September 20, 2	2016-09-20
Cycloalkenyl aryl derivatives for CETP inhibitor Grant 9,371,294 - Lee , et al. June 21, 2	2016-06-21
Novel Compounds For Selective Histone Deacetylase Inhibitors, And Pharmaceutical Composition Comprising The Same App 20160083354 - LEE; Changsik ; et al.	2016-03-24
N-acylhydrazone Derivatives For Selective T Cell Inhibitor And Anti-lymphoid Malignancy Drug App 20150252030 - Choi; HoJin ; et al.	2015-09-10
Cycloalkenyl Aryl Derivatives For Cetp Inhibitor App 20150119376 - LEE; SeoHee ; et al.	2015-04-30
Hydroxamate Derivatives For Hdac Inhibitor, And The Pharmaceutical Composition Comprising Thereof App 20140315889 - Kim; Yuntae ; et al.	2014-10-23
Cycloalkenyl Aryl Derivatives For Cetp Inhibitor App 20140031335 - Lee; SeoHee ; et al.	2014-01-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.